संपर्क करें
कम्पनी के बारे में
Equillium Inc is a biotechnology company that develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with an unmet medical need. Its primary product candidate is EQ001, which is a clinical-stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus, and multiple sclerosis.
US
अनजान
सत्यापित कंपनी नहीं
व्यापार पारदर्शिता
- कंपनी की जानकारी सत्यापित नहीं की
- समीक्षा के लिए अपने ग्राहकों से पूछें
- नकारात्मक समीक्षाओं का जवाब नहीं दिया